Abstract
The most common health problem encountered in international travellers to tropical and subtropical areas is diarrhoea. Even though it is not a life-threatening condition, it may influence deeply the quality of a vacation or the success of a business trip. The majority of cases of travellers’ diarrhoea are due to bacterial pathogens, but viruses and parasites have also been implicated in a minority of patients.
It is advocated that travellers with diarrhoea provide themselves with sources of salt (crackers or soup) and mineral water, to prevent and treat dehydration. Otherwise, treatment recommendations follow illness severity. For mild cases, symptomatic relief alone can be recommended. Loperamide is an effective agent improving diarrhoea and associated symptoms. For moderate diarrhoea (requiring a forced change in itinerary) combination therapy is advised using a fluoroquinolone together with loperamide. Severe diarrhoea [fever >38°C, dysentery (bloody stools) or incapacitating symptoms] should prompt the voyager to take an antibiotic alone for 3 to 5 days. Loperamide is relatively contraindicated in these cases.
For the minority of patients receiving chemoprophylaxis to prevent travellers’ diarrhoea, fluoroquinolones taken once a day while in the area at risk produce the highest protection rate (up to 95%). However, most authorities do not recommend routine prophylaxis for travellers.
Similar content being viewed by others
References
Handszuh H, Waters SR. Travel and tourism patterns. In: DuPont HL, Steffen R, editors. Textbook of travel medicine and health. Hamilton (Ont): BC Decker Inc., 1997
Gorbach SL, Edelman R. Travelers diarrhea: National Institutes of Health Consensus Conference. JAMA 1985; 253: 2700–4
Ericsson CD, DuPont HL. Travelers diarrhea: approaches to prevention and treatment. Clin Infect Dis 1993 May; 16: 616–24
Merson MH, Morris GK, Sack DA, et al. Travelers diarrhea in Mexico. N Engl J Med 1976 Jun 10; 294(24): 1299–305
BeechamIII HJ, Lebron CI, Echeverria P. Short report: impact of traveler’s diarrhea on United States troops deployed to Thailand. Am J Trop Med Hyg 1997; 57: 699–701
Black RE. Epidemiology of travelers diarrhea and relative importance of various pathogens. Rev Infect Dis 1990 Jan–Feb; 12 (1 Suppl.): 73S–9S
Echeverria P, Blacklow NR, Sanford LB, et al. Travelers diarrhea among American peace corps volunteers in rural Thailand. J Infect Dis 1981 Jun; 143(6): 767–71
Taylor DN, Houston R, Shlim DR, et al. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA 1988 Sep 2; 260(9): 1245–8
Taylor DN, Blaser MJ, Blacklow N, et al. Polymicrobial aetiology of travellers diarrhoea. Lancet 1985 Feb 16; 1: 381–3
Ericsson CD, DuPont HL, Mathewson JJ, et al. Treatment of travelers diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA 1990 Jan 12; 263(2): 257–61
Ericsson CD, Nicholls-Vasquez I, DuPont HL, et al. Optimal dosing of trimethoprim-sulfamethoxazole when used with loperamide to treat travelers diarrhea. Antimicrob Agents Chemother 1992 Dec; 36(12): 2821–4
DuPont HL, Ericsson CD, Mathewson JJ, et al. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 1992 Apr 8; 267(14): 1932–5
Bourgeois AL, Gardiner CH, Thornton SA, et al. Etiology of acute diarrhea among United States military personnel deployed to South America and West Africa. Am J Trop Med Hyg 1993; 48(2): 243–8
Ericsson CD, DuPont HL, Mathewson JJ. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of travelers diarrhea. J Travel Med 1997; 4: 3–7
Adkins H, Merrell B. Travelers diarrhea among U.S. Navy and Marine Corps personnel during a Western Pacific deployment. Mil Med 1990 Mar; 155(2): 111–6
Hyams KC, Bourgeois AL, Merrell BR, et al. Diarrheal disease during Operation Desert Shield. N Engl J Med 1991 Nov 14; 325(20): 1423–8
Petruccelli BP, Murphy GS, Sanchez JL, et al. Treatment of travelers diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992 Mar; 165: 557–60
Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995 Sep; 21: 536–41
Taylor DN, Sanchez JL, Candler W, et al. Treatment of travelers diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. Ann Intern Med 1991 May 1; 114(9): 731–4
Haberberger RL, Mikhail IA, Burans JP, et al. Travelers diarrhea among United States military personnel during joint American-Egyptian armed forces exercises in Cairo, Egypt. Mil Med 1991 Jan; 156(1): 27–30
Haberberger RL, Scott DA. Diarrheal disease aboard a U.S. Navy ship after a brief port visit to a high risk area. Mil Med 1994 Jun; 159(6): 445–8
Mattila L, Peltola H, Siitonen A, et al. Short-term treatment of travelers diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 1993 Oct; 17: 779–82
Gascon J, Vila J, Valls ME, et al. Etiology of travellers diarrhea in Spanish travellers to developing countries. Eur J Epidemiol 1993 March; 9(2): 217–23
Steffen R, Jori J, DuPont HL, et al. Treatment of travellers diarrhoea with fleroxacin: a case study. J Antimicrob Chemother 1993; 31: 767–76
DuPont HL, Capsuto EG. Persistent diarrhea in travelers. Clin Infect Dis 1996 Jan; 22: 124–8
DuPont HL, Sanchez JF, Ericsson CD, et al. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med 1990 Jun 20; 88 (6A Suppl.): 15S–9S
Silberschmidt G, Schick MT, Steffen R, et al. Treatment of travellers diarrhoea: zaldaride compared with loperamide and placebo. Eur J Gastroenterol Hepatol 1995; 7: 871–5
DuPont HL, Hornick RB. Adverse effect of lomotil therapy in shigellosis. JAMA 1973 Dec 24–31; 226(13): 1525–8
Salam I, Katelaris P, Leigh-Smith S, et al. Randomised trial of single-dose ciprofloxacin for travellers’ diarrhoea. Lancet 1994; 344: 1537–9
Kaplan JE, Masur H, Holmes KK, et al. Prevention of opportunistic infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1997 Oct; 25 (3 Suppl.): 299S–335S
DuPont HL, Ericsson CD, DuPont MW, et al. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am J Med 1990 Jun 20; 88 (6A Suppl.): 20S–3S
Barry M, Bia F. Pregnancy and travel. JAMA 1989 Feb 3; 261(5): 728–31
Kozicki M, Steffen R, Schär M. ‘Boil it, cook it, peel it or forget it’: does this rule prevent travellers diarrhoea? Int J Epidemiol 1985; 14(1): 169–72
Rademaker CM, Hoepelman IM, Wolfhagen MJ, et al. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers diarrhea. Eur J Clin Microbiol Infect Dis 1989 Aug; 8(8): 690–4
Wenneras C, Svennerholm AM, Ahren C, et al. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun 1992 Jul; 60: 2605–11
Savarino SJ, Brown M, Hall E, et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis 1998 Mar; 177: 796–9
Ericsson CD, DuPont HL, Sullivan P, et al. Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers’ diarrhea. Ann Intern Med 1983; 98: 20–5
DuPont HL, Ericsson CD, Mathewson JJ, et al. Rifaximin, a nonabsorbed antimicrobial in the therapy of travelers’ diarrhea. Digestion. In press
DuPont HL, Ericsson CD, Mathewson JJ, et al. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers’ diarrhea. Gastroenterology 1993 Mar; 104: 709–15
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caeiro, JP., DuPont, H.L. Management of Travellers’ Diarrhoea. Drugs 56, 73–81 (1998). https://doi.org/10.2165/00003495-199856010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199856010-00007